{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/f42701bf-0587-40dc-b698-a09087aea74f/efcf269f-cad6-49e5-bb1a-1c3da1960a9c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Chapter 4: three kinds of failure","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/62f26f5bca2a725a46f6e899/62f26f60bde9e30013c63d52.png?height=200","description":"<p>Stumbling out of the gate ⬩ Launch of Vitravene ⬩ Questions about antisense ⬩ The field thins ⬩ Clinical failure ⬩ The darkest days</p>","author_name":"Nature Biotechnology"}